180 related articles for article (PubMed ID: 36644209)
1. Expression of risk genes linked to vitamin D receptor super-enhancer regions and their association with phenotype severity in multiple sclerosis.
Orton SM; Sangha A; Gupta M; Martens K; Metz LM; de Koning APJ; Pfeffer G
Front Neurol; 2022; 13():1064008. PubMed ID: 36644209
[TBL] [Abstract][Full Text] [Related]
2. The Association Between Vitamin D and Multiple Sclerosis Risk: 1,25(OH)
Lu M; McComish BJ; Burdon KP; Taylor BV; Körner H
Front Immunol; 2019; 10():488. PubMed ID: 30941131
[TBL] [Abstract][Full Text] [Related]
3. Vitamin D receptor (VDR) gene SNPs influence VDR expression and modulate protection from multiple sclerosis in HLA-DRB1*15-positive individuals.
Agliardi C; Guerini FR; Saresella M; Caputo D; Leone MA; Zanzottera M; Bolognesi E; Marventano I; Barizzone N; Fasano ME; Al-Daghri N; Clerici M
Brain Behav Immun; 2011 Oct; 25(7):1460-7. PubMed ID: 21664963
[TBL] [Abstract][Full Text] [Related]
4. Vitamin D metabolic pathway genes and risk of multiple sclerosis in Canadians.
Orton SM; Ramagopalan SV; Para AE; Lincoln MR; Handunnetthi L; Chao MJ; Morahan J; Morrison KM; Sadovnick AD; Ebers GC
J Neurol Sci; 2011 Jun; 305(1-2):116-20. PubMed ID: 21440908
[TBL] [Abstract][Full Text] [Related]
5. Vitamin D receptor binding, chromatin states and association with multiple sclerosis.
Disanto G; Sandve GK; Berlanga-Taylor AJ; Ragnedda G; Morahan JM; Watson CT; Giovannoni G; Ebers GC; Ramagopalan SV
Hum Mol Genet; 2012 Aug; 21(16):3575-86. PubMed ID: 22595971
[TBL] [Abstract][Full Text] [Related]
6. Vitamin D and Genetic Susceptibility to Multiple Sclerosis.
Scazzone C; Agnello L; Bivona G; Lo Sasso B; Ciaccio M
Biochem Genet; 2021 Feb; 59(1):1-30. PubMed ID: 33159645
[TBL] [Abstract][Full Text] [Related]
7. FokI vitamin D receptor gene polymorphism in association with multiple sclerosis risk and disability progression in Slovaks.
Čierny D; Michalik J; Kurča E; Dobrota D; Lehotský J
Neurol Res; 2015 Apr; 37(4):301-8. PubMed ID: 25376135
[TBL] [Abstract][Full Text] [Related]
8. Expression of vitamin D receptor and metabolizing enzymes in multiple sclerosis-affected brain tissue.
Smolders J; Schuurman KG; van Strien ME; Melief J; Hendrickx D; Hol EM; van Eden C; Luchetti S; Huitinga I
J Neuropathol Exp Neurol; 2013 Feb; 72(2):91-105. PubMed ID: 23334593
[TBL] [Abstract][Full Text] [Related]
9. Vitamin D receptor gene is epigenetically altered and transcriptionally up-regulated in multiple sclerosis.
Ayuso T; Aznar P; Soriano L; Olaskoaga A; Roldán M; Otano M; Ajuria I; Soriano G; Lacruz F; Mendioroz M
PLoS One; 2017; 12(3):e0174726. PubMed ID: 28355272
[TBL] [Abstract][Full Text] [Related]
10. Association of serum levels and receptor genes BsmI, TaqI and FokI polymorphisms of vitamin D with the severity of multiple sclerosis.
Moosavi E; Rafiei A; Yazdani Y; Eslami M; Saeedi M
J Clin Neurosci; 2021 Feb; 84():75-81. PubMed ID: 33485603
[TBL] [Abstract][Full Text] [Related]
11. Association of vitamin D receptor polymorphisms with vitamin D and calcium levels in Turkish multiple sclerosis patients.
Elkama A; Orhan G; Karahalil B
Neurodegener Dis Manag; 2022 Dec; 12(6):323-331. PubMed ID: 35848285
[TBL] [Abstract][Full Text] [Related]
12. Long noncoding RNAs associated with phenotypic severity in multiple sclerosis.
Gupta M; Martens K; Metz LM; de Koning AJ; Pfeffer G
Mult Scler Relat Disord; 2019 Nov; 36():101407. PubMed ID: 31563073
[TBL] [Abstract][Full Text] [Related]
13. Polymorphisms in vitamin D metabolism related genes and risk of multiple sclerosis.
Simon KC; Munger KL; Xing Yang ; Ascherio A
Mult Scler; 2010 Feb; 16(2):133-8. PubMed ID: 20007432
[TBL] [Abstract][Full Text] [Related]
14. VDR and CYP24A1 Expression Analysis in Iranian Relapsing-Remitting Multiple Sclerosis Patients.
Sadeghi H; Taheri M; Sajadi E; Movafagh A; Arsang Jang S; Sayad A
Cell J; 2017 Oct; 19(3):352-360. PubMed ID: 28836398
[TBL] [Abstract][Full Text] [Related]
15. Exonic variants of genes related to the vitamin D signaling pathway in the families of familial multiple sclerosis using whole-exome next generation sequencing.
Pytel V; Matías-Guiu JA; Torre-Fuentes L; Montero-Escribano P; Maietta P; Botet J; Álvarez S; Gómez-Pinedo U; Matías-Guiu J
Brain Behav; 2019 Apr; 9(4):e01272. PubMed ID: 30900415
[TBL] [Abstract][Full Text] [Related]
16. Novel modulating effects of PKC family genes on the relationship between serum vitamin D and relapse in multiple sclerosis.
Lin R; Taylor BV; Simpson S; Charlesworth J; Ponsonby AL; Pittas F; Dwyer T; van der Mei IA
J Neurol Neurosurg Psychiatry; 2014 Apr; 85(4):399-404. PubMed ID: 23868949
[TBL] [Abstract][Full Text] [Related]
17. Vitamin D-gene interactions in multiple sclerosis.
Berlanga-Taylor AJ; Disanto G; Ebers GC; Ramagopalan SV
J Neurol Sci; 2011 Dec; 311(1-2):32-6. PubMed ID: 22000399
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-22 Level in Patients with Multiple Sclerosis and Its Relationship with Vitamin D and Vitamin D Receptor Levels.
Khedr AMB; Shaker OG; Hassan A; Hussein M; Kamal YS; Azouz TA
Neuroimmunomodulation; 2022; 29(2):128-134. PubMed ID: 34537762
[TBL] [Abstract][Full Text] [Related]
19. Vitamin D receptor biochemical and genetic profiling and HLA-class II genotyping among Lebanese with multiple sclerosis - A pilot study.
Yamout B; Karaky NM; Mahfouz RAR; Jaber F; Estaitieh N; Shamaa D; Abbas F; Hoteit R; Daher RT
J Neuroimmunol; 2016 Apr; 293():59-64. PubMed ID: 27049563
[TBL] [Abstract][Full Text] [Related]
20. Vitamin D receptor gene polymorphisms are associated with multiple sclerosis in Mexican adults.
Bermúdez-Morales VH; Fierros G; Lopez RL; Martínez-Nava G; Flores-Aldana M; Flores-Rivera J; Hernández-Girón C
J Neuroimmunol; 2017 May; 306():20-24. PubMed ID: 28385183
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
